Feature

U.S. sees most flu hospitalizations in a decade


 

The number of Americans hospitalized because of the flu has hit the highest levels the country has seen in at least a decade, the Centers for Disease Control and Prevention said.

But the number of deaths and outpatient visits for flu or flu-like illnesses was down slightly from the week before, the CDC said in its weekly FluView report.

There were almost 26,000 new hospital admissions involving laboratory-confirmed influenza over those 7 days, up by over 31% from the previous week, based on data from 5,000 hospitals in the HHS Protect system, which tracks and shares COVID-19 data.

The cumulative hospitalization rate for the 2022-2023 season is 26.0 per 100,000 people, the highest seen at this time of year since 2010-2011, the CDC said, based on data from its Influenza Hospitalization Surveillance Network, which includes hospitals in select counties in 13 states.

At this point in the 2019-2020 season, just before the COVID-19 pandemic began, the cumulative rate was 3.1 per 100,000 people, the CDC’s data show.

On the positive side, the proportion of outpatient visits for influenza-like illness dropped slightly to 7.2%, from 7.5% the week before. But these cases from the CDC’s Outpatient Influenza-like Illness Surveillance Network are not laboratory confirmed, so the data could include people with the flu, COVID-19, or respiratory syncytial virus.

The number of confirmed flu deaths for the week of Nov. 27 to Dec. 3 also fell slightly from the last full week of November, 246 vs. 255, but the number of pediatric deaths rose from 2 to 7, and total deaths in children are already up to 21 for 2022-2023. That’s compared to 44 that were reported during all of the 2021-2022 season, the CDC said.

“So far this season, there have been at least 13 million illnesses, 120,000 hospitalizations, and 7,300 deaths from flu,” the agency estimated.

A version of this article first appeared on Medscape.com.

Recommended Reading

U.S. flu activity already at mid-season levels
Clinician Reviews
What is the genetic influence on the severity of COVID-19?
Clinician Reviews
Buzzy Lancet long COVID paper under investigation for ‘data errors’
Clinician Reviews
RSV surge stuns parents and strains providers, but doctors offer help
Clinician Reviews
FDA pulls U.S. authorization for Eli Lilly’s COVID drug bebtelovimab
Clinician Reviews
Study comparing surgical and N95 masks sparks concern
Clinician Reviews
Children and COVID: Hospitalizations provide a tale of two sources
Clinician Reviews
Paxlovid has been free so far. Next year, sticker shock awaits
Clinician Reviews
How a cheap liver drug may be the key to preventing COVID
Clinician Reviews
As COVID treatments dwindle, are new ones waiting in the wings?
Clinician Reviews